Annual CFO
-$13.41 M
-$327.00 K-2.50%
December 31, 2023
Summary
- As of February 7, 2025, INDP annual cash flow from operations is -$13.41 million, with the most recent change of -$327.00 thousand (-2.50%) on December 31, 2023.
- During the last 3 years, INDP annual CFO has fallen by -$10.08 million (-303.22%).
- INDP annual CFO is now -303.22% below its all-time high of -$3.32 million, reached on December 31, 2020.
Performance
INDP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$2.51 M
-$35.00 K-1.41%
September 1, 2024
Summary
- As of February 7, 2025, INDP quarterly cash flow from operations is -$2.51 million, with the most recent change of -$35.00 thousand (-1.41%) on September 1, 2024.
- Over the past year, INDP quarterly CFO has dropped by -$35.00 thousand (-1.41%).
- INDP quarterly CFO is now -204.38% below its all-time high of -$825.60 thousand, reached on March 31, 2021.
Performance
INDP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$11.53 M
+$1.22 M+9.58%
September 1, 2024
Summary
- As of February 7, 2025, INDP TTM cash flow from operations is -$11.53 million, with the most recent change of +$1.22 million (+9.58%) on September 1, 2024.
- Over the past year, INDP TTM CFO has increased by +$1.22 million (+9.58%).
- INDP TTM CFO is now -1296.49% below its all-time high of -$825.60 thousand, reached on March 31, 2021.
Performance
INDP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
INDP Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.5% | -1.4% | +9.6% |
| 3 y3 years | -303.2% | -19.3% | +16.9% |
| 5 y5 years | -303.2% | -19.3% | +16.9% |
INDP Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.7% | at low | -19.3% | +49.4% | -2.1% | +25.3% |
| 5 y | 5-year | -303.2% | at low | -204.4% | +55.4% | -1296.5% | +25.3% |
| alltime | all time | -303.2% | at low | -204.4% | +55.4% | -1296.5% | +25.3% |
Indaptus Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.51 M(+1.4%) | -$11.53 M(-9.6%) |
| Jun 2024 | - | -$2.48 M(-37.1%) | -$12.75 M(+3.0%) |
| Mar 2024 | - | -$3.94 M(+51.3%) | -$12.38 M(-7.7%) |
| Dec 2023 | -$13.41 M(+2.5%) | -$2.60 M(-30.3%) | -$13.41 M(+3.0%) |
| Sep 2023 | - | -$3.73 M(+77.3%) | -$13.01 M(-6.2%) |
| Jun 2023 | - | -$2.11 M(-57.5%) | -$13.88 M(-7.0%) |
| Mar 2023 | - | -$4.96 M(+124.4%) | -$14.92 M(+14.1%) |
| Dec 2022 | -$13.08 M | -$2.21 M(-52.0%) | -$13.08 M(-9.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$4.60 M(+46.2%) | -$14.41 M(-6.7%) |
| Jun 2022 | - | -$3.15 M(+1.0%) | -$15.44 M(+13.6%) |
| Mar 2022 | - | -$3.12 M(-11.9%) | -$13.58 M(+20.3%) |
| Dec 2021 | -$11.29 M(+239.6%) | -$3.54 M(-37.1%) | -$11.29 M(+45.7%) |
| Sep 2021 | - | -$5.63 M(+334.9%) | -$7.75 M(+265.6%) |
| Jun 2021 | - | -$1.29 M(+56.8%) | -$2.12 M(+156.8%) |
| Mar 2021 | - | -$825.60 K | -$825.60 K |
| Dec 2020 | -$3.32 M | - | - |
FAQ
- What is Indaptus Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Indaptus Therapeutics?
- What is Indaptus Therapeutics annual CFO year-on-year change?
- What is Indaptus Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Indaptus Therapeutics?
- What is Indaptus Therapeutics quarterly CFO year-on-year change?
- What is Indaptus Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Indaptus Therapeutics?
- What is Indaptus Therapeutics TTM CFO year-on-year change?
What is Indaptus Therapeutics annual cash flow from operations?
The current annual CFO of INDP is -$13.41 M
What is the all time high annual CFO for Indaptus Therapeutics?
Indaptus Therapeutics all-time high annual cash flow from operations is -$3.32 M
What is Indaptus Therapeutics annual CFO year-on-year change?
Over the past year, INDP annual cash flow from operations has changed by -$327.00 K (-2.50%)
What is Indaptus Therapeutics quarterly cash flow from operations?
The current quarterly CFO of INDP is -$2.51 M
What is the all time high quarterly CFO for Indaptus Therapeutics?
Indaptus Therapeutics all-time high quarterly cash flow from operations is -$825.60 K
What is Indaptus Therapeutics quarterly CFO year-on-year change?
Over the past year, INDP quarterly cash flow from operations has changed by -$35.00 K (-1.41%)
What is Indaptus Therapeutics TTM cash flow from operations?
The current TTM CFO of INDP is -$11.53 M
What is the all time high TTM CFO for Indaptus Therapeutics?
Indaptus Therapeutics all-time high TTM cash flow from operations is -$825.60 K
What is Indaptus Therapeutics TTM CFO year-on-year change?
Over the past year, INDP TTM cash flow from operations has changed by +$1.22 M (+9.58%)